Results 211 to 220 of about 33,038 (222)

Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer

Trends in Pharmacological Sciences, 2016
Jan Kroon, Joonhui Kim, Sander Kooijman   +2 more
exaly  

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Annals of Oncology, 2010
, K A Boehm, F Zhan
exaly  

Chemotherapy in patients with castration-resistant prostate cancer

European Journal of Cancer, 2009
Meulenbeld, Hielke, Hamberg, Paul, de Wit, Ronald   +2 more
openaire   +2 more sources

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer

Annals of Oncology, 2019
A Lopez-Gitlitz, B A Hadaschik, D Olmos   +2 more
exaly  

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Lancet, The, 2011
, Piotr Milecki, Lawrence Karsh
exaly  

<p>Darolutamide For Castration-Resistant Prostate Cancer</p>

OncoTargets and Therapy, 2019
Diogo Assed Bastos, Emmanuel Stylianos Antonarakis   +1 more
exaly  

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

Annals of Oncology, 2009
Leon Terstappen, Hendrik-Tobias Arkenau, Gerhardt Attard   +2 more
exaly  

Castrate-Resistant Prostate Cancer

2014
openaire   +1 more source

Phospho‐MED1‐enhanced UBE2C locus looping drives castration‐resistant prostate cancer growth

EMBO Journal, 2011
Xiaoting Zhang, Zhong Chen, Qianben Wang   +2 more
exaly  

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

New England Journal of Medicine, 2010
, Philip Kantoff
exaly